Vorinostat as a radiosensitizer for brain metastasis: a phase I clinical trial
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Vorinostat as a radiosensitizer for brain metastasis: a phase I clinical trial
Authors
Keywords
Vorinostat, Phase I, Brain metastasis, Whole brain radiation, Radiosensitizer
Journal
JOURNAL OF NEURO-ONCOLOGY
Volume 118, Issue 2, Pages 313-319
Publisher
Springer Nature
Online
2014-04-12
DOI
10.1007/s11060-014-1433-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Phase I–II study of vorinostat plus paclitaxel and bevacizumab in metastatic breast cancer: evidence for vorinostat-induced tubulin acetylation and Hsp90 inhibition in vivo
- (2011) B. Ramaswamy et al. BREAST CANCER RESEARCH AND TREATMENT
- A randomized phase II study of two doses of vorinostat in combination with 5-FU/LV in patients with refractory colorectal cancer
- (2011) M. G. Fakih et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Cooperation of the HDAC inhibitor vorinostat and radiation in metastatic neuroblastoma: Efficacy and underlying mechanisms
- (2011) Sabine Mueller et al. CANCER LETTERS
- Phase I Study of Decitabine in Combination with Vorinostat in Patients with Advanced Solid Tumors and Non-Hodgkin's Lymphomas
- (2011) Anastasios Stathis et al. CLINICAL CANCER RESEARCH
- Phase II trial of vorinostat in combination with bortezomib in recurrent glioblastoma: a north central cancer treatment group study
- (2011) B. B. Friday et al. NEURO-ONCOLOGY
- Phase I trial of vorinostat combined with bevacizumab and CPT-11 in recurrent glioblastoma
- (2011) Prakash Chinnaiyan et al. NEURO-ONCOLOGY
- Gastrointestinal toxicity of vorinostat: reanalysis of phase 1 study results with emphasis on dose-volume effects of pelvic radiotherapy
- (2011) Åse Bratland et al. Radiation Oncology
- Clinical Trial Design in Brain Metastasis: Approaches for a Unique Patient Population
- (2011) David M. Peereboom Current Oncology Reports
- Phase I study of vorinostat (suberoylanilide hydroxamic acid, NSC 701852) in combination with docetaxel in patients with advanced and relapsed solid malignancies
- (2010) Bryan J. Schneider et al. INVESTIGATIONAL NEW DRUGS
- Phase I Study of Vorinostat in Patients With Advanced Solid Tumors and Hepatic Dysfunction: A National Cancer Institute Organ Dysfunction Working Group Study
- (2010) Suresh S. Ramalingam et al. JOURNAL OF CLINICAL ONCOLOGY
- Vorinostat, a histone deacetylase inhibitor, combined with pelvic palliative radiotherapy for gastrointestinal carcinoma: the Pelvic Radiation and Vorinostat (PRAVO) phase 1 study
- (2010) Anne Hansen Ree et al. LANCET ONCOLOGY
- Stereotactic Radiosurgery for the Management of Brain Metastases
- (2010) John H. Suh NEW ENGLAND JOURNAL OF MEDICINE
- Inhibition of Radiation-Induced DNA Repair and Prosurvival Pathways Contributes to Vorinostat-Mediated Radiosensitization of Pancreatic Cancer Cells
- (2010) Amit Deorukhkar et al. PANCREAS
- Vorinostat Inhibits Brain Metastatic Colonization in a Model of Triple-Negative Breast Cancer and Induces DNA Double-Strand Breaks
- (2009) D. Palmieri et al. CLINICAL CANCER RESEARCH
- Phase II Trial of Vorinostat in Recurrent Glioblastoma Multiforme: A North Central Cancer Treatment Group Study
- (2009) Evanthia Galanis et al. JOURNAL OF CLINICAL ONCOLOGY
- Vorinostat enhances the radiosensitivity of a breast cancer brain metastatic cell line grown in vitro and as intracranial xenografts
- (2009) A. Baschnagel et al. MOLECULAR CANCER THERAPEUTICS
- Current Neurosurgical Management of Brain Metastases
- (2008) David W. Andrews SEMINARS IN ONCOLOGY
- A New Prognostic Index and Comparison to Three Other Indices for Patients With Brain Metastases: An Analysis of 1,960 Patients in the RTOG Database
- (2007) Paul W. Sperduto et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now